Freenome is an AI-powered cancer detection company developing multi-cancer early detection blood tests using machine learning to analyze cell-free DNA and protein biomarkers. Its multiomics platform aims to detect cancer earlier when it is more treatable.
Category
Healthcare
Subcategory
Clinical AI
Free Tier
Not available yet
Paid Plans
Laboratory and healthcare provider partnerships
API Cost
Not available yet
Web App
Freenome Trust & Security Report
Certifications, AI-training posture, and security controls, with sourced proof.
●CLIA (Clinical Laboratory Improvement Amendments)●Data Privacy Framework (EU-U.S., UK Extension, Swiss-U.S.)
Verified against Freenome's own trust and security pages. See the full report for sourced proof →
Region
United States (on-premises servers); international transfers via standard contractual clauses or adequacy decisions
Self-hostable
No
Early detection of colorectal cancer through blood testingMulti-cancer screening programs for at-risk populationsResearch partnerships for cancer biomarker discoveryClinical validation studies for liquid biopsy testsImproving cancer survival rates through earlier diagnosis
// MORE IN CLINICAL AI
InfermedicaHealthcareClinical AIVerified
#clinical decision support#symptom assessment
Viz.aiHealthcareClinical AIVerified
#medical imaging#stroke detection
TempusHealthcareClinical AIVerified
#precision medicine#oncology